CAR-T Cell Therapy market Growth Analysis and Forecast by 2035

Fill Finish Biopharmaceuticals market Growth Opportunity and Industry Forecast to 2035 Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products. This evident surge in the demand for biologics fill finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities. The financial opportunity within the biologics fill / finish services market has been analysed across the following segments:  Type of Packaging Container  Ampoules  Cartridges  Syringes  Vials  Type of Biologic  Antibodies  Cell Therapies  Gene Therapies  Oligonucleotides  Proteins / Peptides  Vaccines  Others  Therapeutic Area  Oncological Disorders  Autoimmune Disorders  Infectious Diseases  Cardiovascular Disorders  Other Disorders  Scale of Operation  Preclinical / Clinical  Commercial  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:  AbbVie Contract Manufacturing  Asymchem  BioReliance  Boehringer Ingelheim BioXcellence  Catalent Biologics  Charles River Laboratories  Fareva  Fresenius Kabi  Glaxo SmithKline  Hetero Drugs  Intas Pharmaceuticals  Lonza  Patheon  Pierre Fabre  Recipharm  Samsun Biologics  Syngene  Takara Bio  Wacker Biotech  WuXi AppTec  WuXi Biologics Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Biologics Fill / Finish Service Providers: Market Landscape 5. Company Competitiveness Analysis 6. Biologics Fill / Finish Service Providers in North America 7. Biologics Fill / Finish Service Providers in Europe 8. Biologics Fill / Finish Service Providers in Asia-Pacific 9. Recent Partnerships 10. Recent Expansions 11. Capacity Analysis 12. Demand Analysis 13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish 14. Regional Capability Assessment 15. Market Sizing and Opportunity Analysis 16. Future Growth Opportunities 17. Case Study: Robotic Systems in Fill / Finish Operations 18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish 19. Concluding Remarks 20. Executive Insights 21. Appendix 1: Tabulated Data 22. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/biologics-fill-finish-services-market/256.html You may also be interested in the following titles: Global Antibiotics Market Pharmaceutical Polymers / Medical Polymers Market Modular facility manufacturers market Cell therapy manufacturing market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #FillFinishBiopharmaceuticalsMarketGrowth #FillFinishBiopharmaceuticalsMarketTrends #biologicsfillfinish #finishservicesmarket #BiologicsPackaging

Digital Therapeutics market Trends, Analysis by 2035 The rise in the demand for convenient treatment options for patients across all age groups, specifically post COVID 19, has tremendously increased the adoption of digital therapeutics. This led to the integration of digital therapeutics solutions into routine healthcare and has helped in overcoming geographical barriers by enabling patients to access healthcare in quick, effective and cost-efficient manner. Several industry / non-industry players have shown a keen interest in digital therapeutics; with increasing adoption of such solutions, we expect the domain to present numerous lucrative investment opportunities. The financial opportunity within the digital therapeutics market has been analyzed across the following segments:  Type of Solution  Standalone Software Application  Combination Offerings of Software Application + Device  Combination Offerings of Software Application + AI Support  Combination Offerings of Software Application + Personal Coach  Combination Offerings of Software Application + Device + AI Support  Combination Offerings of Software Application + Device + Personal Coach  Others  Type of Therapy  Curative Solution  Preventive Solution  Therapeutic Area  Cardiovascular Disorders  Mental Health Problems  Metabolic Disorders  Neurological Disorders  Pain Management  Respiratory Disorders  Sleep Disorders  Substance Use Disorders  Others  Key Geographical Regions  North America  Europe  Asia-Pacific and Rest of the World The Investor Series: Opportunities in Digital Therapeutics Market, detailed profiles of the key public ventures engaged in the development of digital therapeutics solutions; each profile features a brief overview of the company, details on its management team, insights from its balance sheet (if available), details on its product / service portfolio, recent developments and key financial details (including company investment highlights, company fundamental and company technical analysis). Table of Contents Excel Deliverables 1. Innovators and Product Dataset 2. Funding and Investment Analysis 3. Fundamental and Technical Financial Analysis 4. Business Risk Analysis 5. Market Forecast and Opportunity Analysis 6. Return on Investment PowerPoint Deliverable 1. Context 2. Project Approach 3. Project Objective 4. Executive Summary Section I: Need for Digital Therapeutics and Innovators Landscape 5. The Digital Health Market 6. Digital Therapeutics: Innovator Landscape 7. Digital Therapeutics: Product Landscape and Company Health Indexing 8. Value Proposition Analysis 9. Company Competitiveness Analysis Section II: Analysis of Investments 10. Funding and Investment Analysis Section III: Financial Analysis and Assessment of Business Risks 11. Financial Analysis of Public Ventures 12. Company Profiles of Public Ventures 13. Business Risk Analysis Section IV: Market Forecast and Opportunity Analysis 14. Market Forecast Section V: Analysis of Returns on Investment and Key Acquisition Targets 15. Analysis of Return on Investment 16. Key Acquisition Targets 17. Conclusion 18. Appendices To view more details on this report, click on the link https://www.rootsanalysis.com/reports/opportunities-in-digital-therapeutics-market.html You may also be interested in the following titles: Conjugation and Labeling Services Market Bispecific Antibodies Market Viral Clearance and Testing Services Market Genotoxicity Testing and Mutagenicity Testing Services Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #DigitalTherapeuticsMarket #DigitalTherapeuticsMarketSize #Digitalhealth #prescriptiondigitaltherapeutics #Digitalhealthcompanies

Lab Automation market Analysis and Trends by 2022-2035 The diverse applications of lab automation systems, including advanced data management, high reproducibility and increased productivity in the biotechnology and pharmaceutical industries, have allowed the researchers to focus on more complex tasks. As a result, several stakeholders have been engaged in the manufacturing of user-friendly, controlled and automated instruments that can be customized as per the needs of the laboratory. The USD 7.5 billion (by 2035) financial opportunity within the lab automation market has been analyzed across the following segments:  Stage of Automation  Pre-Analytical  Analytical  Post-Analytical  Total Lab Automation  Type of Instrument  Automated Liquid Handling Systems  Automated Microplate Readers  Automated Sampling Systems  Analyzers  Automated Storage and Retrieval Systems (ASRS)  Other Instruments  End-User  Pharmaceutical and Biotechnology Companies  Research and Diagnostic Laboratories  Other End-Users  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The Lab Automation Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:  Abbott  Anton Paar  BD  Beckman Coulter  ERWEKA  Leuze  Ortho Clinical Diagnostics  Pall Corporation  PerkinElmer  Roche Diagnostics  Siemens Healthineers  SYSTAG Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Company Competitiveness Analysis 6. Company Profiles 7. Partnerships and Collaborations 8. Patent Analysis 9. Market Forecast and Opportunity Analysis 10. Case Study: Lab Automation Software 11. Executive Insights 12. Appendix 1: Tabulated Data 13. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/lab-automation-market.html You may also be interested in the following titles: Gene Switch Market Digital Biomanufacturing Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

Bispecific Antibodies market 2022 – Industry Growth by 2035 Given the recent approval of a number of bispecific antibodies and several ongoing R&D efforts focused on evaluating the potential of such candidates against various disease indications, this sector of the pharmaceutic industry has garnered significant interest of stakeholder The USD 16.8 billion (by 2035) financial opportunity within bispecific antibodies market has been analyzed across the following segments:  Therapeutic Area  Autoimmune Disorders  Genetic Disorders  Hematological Malignancies  Ophthalmic Disorders  Skin Cancers  Solid Tumors  Mechanism of Action  Cytokines Retargeting / Neutralization  Dual Ligands Blocking  Resistance Factors Co-targeting  Targeting Tumor Angiogenesis  T-Cell Retargeting / Activation  Others  Target Antigen  C5-Albumin  CD20 x CD3  CD3 x BCMA  CD3 x CD19  EGFR x cMET  EpCAM x CD3  Factor IXa x Factor X  gp100 x CD3  HER2 x HER2  PD-1 x CTLA-4  PD-L1 x TGFβ  TNF-α x HSA  VEGF x DLL4  VEGF-A x ANG2  Antibody Format  Asymmetric  Fragments  Key Players  Akeso Biopharma  Alexion  Amgen  Genmab  Immunocore  Janssen Research & Development  Linton Pharm  Merck  OncXerna Therapeutics  Pfizer  Roche  Taisho Pharmaceutical  Zymeworks  Key Geographical Regions  Asia  Europe  North America  Rest of the World The Bispecific Antibodies Market, 2023-2035, report features the following companies, which we identified to be key players in this domain:  Akeso Biopharma  Alphamab Oncology  Amgen  Merck  Regeneron  Roche  Xencor Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape of Approved and Clinical Therapies 5. Market Landscape of Preclinical Therapies 6. Key Insights 7. Technology Assessment Framework 8. Big Pharma Players: Benchmarking Analysis 9. Company Profiles 10. Partnerships and Collaborations 11. Contract Services for Bispecific Antibody Therapeutics 12. Clinical Trial Analysis 13. Case Study: Regulatory Guidelines for Bispecific Antibodies 14. Case Study: Promotional / Marketing Strategies 15. Market Forecast and Opportunity Analysis 16. SWOT Analysis 17. Concluding Remarks 18. Executive insights 19. Appendix 1: Tabulated data 20. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html You may also be interested in the following titles: Decentralized Clinical Trials / Virtual Clinical Trials Market Global Antibiotics Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

Investor Series: Opportunities in Women’s Digital Health market 2022 – Industry Growth by 2035 The growing popularity of digital solutions has enabled the development of technological remedies, such as mobile apps, software, wearable devices and diagnostic tools that exclusively aid in improving female health and wellness. Owing to the increased adoption rate of digital solutions and rise in the demand for remote healthcare services, the companies involved in the women’s digital health domain have witnessed a surge in the investment activity. Further, taking into consideration both the historical and modern scenarios, we expect the women’s digital health market to offer numerous lucrative investment opportunities. The financial opportunity within the women’s digital health market has been analyzed across the following segments:  Type of Solution  Applications / Software  Devices  Services  Therapeutic Application Area  Fetal Health  General Wellness  Menstrual Cycle  Pelvic Care  Reproductive Health / Fertility  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  The Investor Series: Opportunities in Women’s Digital Health Market, features detailed profiles of the key public ventures engaged in the development of women’s digital health solutions; each profile features a brief overview of the company, details on its management team, insights from its balance sheet (if available), details on its product / service portfolio, recent developments and key financial details (including company investment highlights, company fundamental and company technical analysis). A detailed analysis of the women's digital health funding and women's digital health investment activity that has taken place, since 2011. Table of Contents Excel Deliverables 1. Innovators and Product Dataset 2. Funding and Investment Analysis 3. Fundamental and Technical Financial Analysis 4. Market Forecast and Opportunity Analysis 5. Return on Investment PowerPoint Deliverable 1. Context 2. Project Objectives 3. Project Approach 4. Executive Summary Section I: Introduction to Women’s Digital Health Solutions and Innovator Landscape 5. The Women’s Digital Health Market 6. Women’s Digital Health: Innovator Landscape 7. Women’s Digital Health: Product Landscape and Company Health Indexing 8. Value Proposition Analysis 9. Company Competitiveness Analysis Section II: Analysis of Investments 10. Funding and Investment Analysis Section III: Financial Analysis of Key Public Ventures 11. Financial Analysis of Public Ventures 12. Company Profiles of Public Ventures Section IV: Market Forecast and Opportunity Analysis 13. Market Forecast and Opportunity Analysis Section V: Key Acquisition Targets, Business Risk Assessment and Return on Investments 14. Key Acquisition Targets 15. Business Risk Assessment 16. Return on Investments 17. Conclusion 18. Appendices Get more details on the report https://www.rootsanalysis.com/reports/opportunities-in-women-digital--health-market.html You may also be interested in the following titles: Non-Viral Transfection Reagents and Systems Market 3D Bioprinting You may also like to learn what our experts are sharing in Roots educational series: Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

Investor Series: Opportunities in RNA Therapeutics market 2022 – Industry Growth by 2035 The new market report titled “Opportunities in the RNA Therapeutics Market”, published by Roots Analysis is one of the most sought-after solutions for investors operating in the RNA therapeutics market. The report will help investors stay updated with the latest market trends and opportunities associated with the RNA therapeutics market. The report comes with a concise summary of the details regarding the historical market data, current market trends, future growth prospects, innovator and product landscape, company health indexing, value proposition analysis, company competitiveness, funding and investment, financial analysis of public ventures, business risk analysis, returns on investment and key acquisition targets, as well as the emerging market trends and opportunities in RNA therapeutics market. The opportunities in the RNA therapeutics market are anticipated to expand significantly. However, the latest report is mainly intended for business leaders, experts, thought leaders, investors, start-ups and growth stage firms interested in RNA Therapeutics business space and is available in the form of PDF and spreadsheet. Investor Series: Opportunities in the RNA Therapeutics Market: Investor Series Scope and Market Size: The report provides detailed information on the RNA therapeutics market, covering the core and peripheral RNA therapeutics solutions. It offers a technical and financial perspective on how the RNA therapeutics market opportunities is likely to evolve, in terms of future business success, over the coming decade. The RNA therapeutics market is broadly segmented on the basis of type of solution, type of therapy, therapeutic area and geographical regions. The segmental growth helps the investors, firms, business leaders to get a lucid picture of the niche pockets of growth, as well as the strategies deployed by the market players to drive the growth of these segments. This section of the report helps them understand and determine the core application areas and the differences between the target markets. The report scrutinizes the RNA therapeutics market in terms of market size & volume and significant information pertaining to product bifurcation and RNA therapeutics solutions overview. Key Market Contenders: This particular section of the RNA therapeutics market report covers all the necessary details of the RNA therapeutics’ solutions developed by players operating in the RNA therapeutics market. The report goes on to elucidate a quantitative perspective on the relative health of the different innovator companies and an assessment of the various solutions, offered by the companies developing DTx solutions, featuring analysis based on number and types of products, and an informed perspective on the value of the offerings based on multiple relevant aspects. Information on the funding and investment activity that has taken place in this domain since 2011 has also been included in this report. Moreover, the exhaustive report presents financing category-wise trends, describing the relative maturity of the innovator companies. Further, RNA therapeutics market features a list of the leading RNA therapeutics investors , based on their participation in financing activity in this industry segment. It also covers an elaborate review of the overall RNA therapeutics market from a financial perspective, including detailed fundamental (insights from the balance sheet, and key financial ratios) and technical analyses (insights from historical and recent stock price variations, and analysis using popular stock performance indicators) of financial data of the publicly listed companies. This section of RNA therapeutics market report focusing on the competitive terrain of the RNA therapeutics market endows the reader with every significant detail and information about the leading competitors on the market. To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/opportunities-in-RNA-therapeutics-market.html You may also be interested in the following titles: Oral Solid Dosage Manufacturing Market Lipid Nanoparticles in Drug Delivery You may also like to learn what our experts are sharing in Roots educational series: Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders 4D Bioprinting Market: Key Trends About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

CRISPR Technologies: Intellectual Property Landscape market 2022 – Industry Growth by 2035 The new market report titled ‘CRISPR Technologies: Intellectual Property Landscape,’ published by Roots Analysis features an extensive study of some of the key historical and contemporary intellectual property (IP) documents, describing the various types of CRISPR Technologies. The insights generated in this report have been presented across two deliverables, namely a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing trend in this domain. To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/crispr-technologies-ip-landscape.html Main Chapters in the CRISPR Technologies Intellectual Property Landscape Report  Overall Intellectual Property Landscape An analytical perspective of the various patents and affiliated IP documents that have been published related to CRISPR Technologies, since 2000. An in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, featuring insightful inferences related to both historical and recent R&D trends within this domain.  Popular / Relevant Prior Art Search Expressions An examination of IP literature, shortlisting key words and phrases used to describe CRISPR Technologies. The analysis also includes details on the historical use of the aforementioned terms across different IP filings, key affiliated terms and other related trends.  Patent Valuation Analysis Competitive benchmarking and valuation analysis of the key members of unique patent families captured in the report, taking into consideration important parameters of the patent application.  Patentability and Freedom to Operate A systematic and Roots Proprietary approach to identify relevant areas of innovation by analyzing published IP documents, by defining the uniqueness of patented / patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions wherein new and / or modified claims may be filed without infringing on existing IP.  Analysis of Patent Applications and Granted CRISPR Technologies Patents A detailed summary of the various patent applications and granted patents across different jurisdictions and their relative value in the IP ecosystem. The analysis classified the intellectual capital in terms of type of innovation and the innovation related to CRISPR Technologies, thereby offering the means to identify active arenas of research and assess innovation-specific IP filing trends.  Pockets of Innovation and White Spaces An insightful analysis of the various CPC codes used in published IP literature and their affiliated families, offering the means to identify historical and existing pockets of innovation, the analysis also features a discussion on prevalent white spaces.  Claim Analysis One of the objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in granted, active patents in the dataset. Using a systematic segregation approach, we have analyzed trends associated with the preamble, type of patent, type of claim and other key elements of a claim. Key Companies Profiled • 10x Genomics • 22nd Century Group • 64x Bio • Aadigen • Aarhus University You may also be interested in the following titles: Quantum Computing in Drug Discovery Services Market Viral Clearance and Viral Testing Services Market You may also like to learn what our experts are sharing in Roots educational series: Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market? Medical Device Coatings and Modification Technologies About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

Modular facilities Manufacturers market Analysis and Trends by 2022-2035 Modular facilities can be an effective way for drug developers and manufacturers to reduce costs, minimize delays, and expedite time-to-market, by utilizing the available infrastructure while operating in accordance with the standard GMP guidelines The financial opportunity within modular facilities market has been analyzed across the following segments:  Size of Facility  Small Plants  Mid-sized Plants  Large Plants  Very Large Plants  Type of Industry Served  Pharmaceutical  Biotechnology  Type of Modular Construct  Hybrid Skid Modular Constructs  Plug-and-Play Modular Constructs  Skid-Mounted Modular Constructs  Truckable Modular Constructs  Others Modular Constructs  Type of Construction Component  Process Equipment  Base Building  Mechanical, Electrical and Plumbing System  Process Commodities  Other Construction Components  Type of Facility  Manufacturing  Aseptic Filling  Research and Development  Others  Scale of Operation  Clinical  Commercial  Type of Product  Cell and Gene Therapies  Vaccines  Biosimilars  Monoclonal Antibodies  Advanced Pharmaceuticals  Sterile Products  Viral Vectors  Other Products  Type of Expansion  New Facilities  Facility Expansions  Planned Expansions  Type of Modular Construction  Relocatable  Permanent  Type of Material  Steel  Wood  Concrete  Key Geographical Regions  North America  Europe  Asia  Middle East and North Africa (MENA)  Rest of the world The Modular Facilities in the Pharmaceutical and Biotech Market, 2023-2035, report features the following companies, which we identified to be key players in this domain:  Cytiva  G-CON Manufacturing  Germfree  IPM Technologies  KeyPlants  ModuleCo Pharma  NNE  Pharmadule Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape: Modular Facility Manufacturers 5. Market Landscape: Modular Cleanroom Providers 6. Modular Facility Manufacturers: Company Competitiveness Analysis 7. Company Profiles 8. Partnerships and Collaborations 9. Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry 10. Facility Construction Trends in the Pharmaceutical Industry 11. Cost, Time Optimization Framework 12. Market Forecast 13. Prevalent and Emerging Trends 14. Future Growth Opportunities 15. Conclusion 16. Executive insights 17. Appendix I: Tabulated data 18. Appendix II: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/modular-manufacturing-market/178.html You may also be interested in the following titles: Cannabis Testing Market Decentralized Clinical Trials / Virtual Clinical Trials Market You may also like to learn what our experts are sharing in Roots educational series: mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends Novel Cell Cytometers: Need of the Hour About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

Deep Learning in Drug Discovery market Growth Opportunity and Industry Forecast to 2035 The traditional statistical tools and techniques available for medical data interpretation are known to be associated with challenges related to time and cost. This has prompted industry stakeholders to explore the applications of deep learning-based technologies, specifically across drug discovery and diagnosis. In addition, recent investments made in this domain are likely to offer lucrative opportunities to companies offering deep learning-based technologies / solutions within the healthcare industry. The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:  Therapeutic Area  Oncological Disorders  Infectious Diseases  Neurological Disorders  Immunological Disorders  Endocrine Disorders  Cardiovascular Disorders  Respiratory Disorders  Ophthalmic Disorders  Musculoskeletal Disorders  Inflammatory Disorders  Other Disorders  Key Geographical Regions  North America  Europe  Asia Pacific  Rest of the World The Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:  Aegicare  Aiforia Technologies  Ardigen  Berg  Google  Huawei  Merative  Nference  NVIDIA  Owkin  Phenomic AI  Pixel AI Table of Contents 1. PREFACE 2. EXECUTIVE SUMMARY 3. INTRODUCTION 4. MARKET OVERVIEW: DEEP LEARNING IN DRUG DISCOVERY 5. MARKET OVERVIEW: DEEP LEARNING IN DIAGNOSTICS 6. COMPANY PROFILES 7. PORTER’S FIVE FORCES ANALYSIS 8. CLINICAL TRIAL ANALYSIS 9. FUNDING AND INVESTMENT ANALYSIS 10. START-UP HEALTH INDEXING 11. COMPANY VALUATION ANALYSIS 12. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DRUG DISCOVERY 13. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DIAGNOSTICS 14. DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS 15. CONCLUDING REMARKS 16. INTERVIEW TRANSCRIPTS 17. APPENDIX 1: TABULATED DATA 18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/deep-learning-in-drug-discovery-market/156.html You may also be interested in the following titles: Gene Switch Market Digital Biomanufacturing Market You may also like to learn what our experts are sharing in Roots educational series: Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities Investment Opportunities in Women’s Digital Health About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com